Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF SignalingReport as inadecuate




Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling - Download this document for free, or read online. Document in PDF available to download.

> Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling Ikuo Nakamura, Kais Zakharia, Bubu A. Banini, Dalia S. Mikhail, Tae Hyo Kim, Ju Dong Yang, Catherine D. Moser, Hassan M. Shaleh, Sarah R. Thornburgh, Ian Walters x Published: November 3, 2015 https:-doi.org-10.1371-journal.pone.0142355 Article Metrics Comments Related Content Reader Comments 0 Media Coverage Reset zoom 1 { %> All Figures Next Previous show more show less Show in Context

Download:

TIFF PNG PPT The following information is missing from the Funding section: This research was supported by a National Institutes of Health NIH grant, 3R01CA165076-03S2, Research Supplement to Promote Diversity in Health-Related Research, to Hassan M. Shaleh.Reference1. Nakamura I, Zakharia K, Banini BA, Mikhail DS, Kim TH, Yang JD, et al. 2014 Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling. PLoS ONE 94: e92273. pmid:24710173 View Article PubMed-NCBI Google Scholar



Author: Ikuo Nakamura, Kais Zakharia, Bubu A. Banini, Dalia S. Mikhail, Tae Hyo Kim, Ju Dong Yang, Catherine D. Moser, Hassan M. Shaleh,

Source: http://plos.srce.hr/



DOWNLOAD PDF




Related documents